Abstract
The review by Gotera that summarized evidences surrounding the available therapeutic agents in patients with coronavirus disease 2019 (COVID-19) is commendable. In addition, the authors listed the possible side effects associated with each of these therapeutic agents, which could serve as a reminder for clinicians who may not be familiar with the safety profile of new or existing but repurposed therapeutic agents for the treatment of COVID-19.
Original language | English |
---|---|
Pages (from-to) | 690-691 |
Number of pages | 2 |
Journal | International Brazilian Journal of Urology |
Volume | 47 |
Issue number | 3 |
DOIs | |
Publication status | Published - May 2021 |
Externally published | Yes |